
    
      This is a prospective, randomized, double-blind parallel group study comparing the effect of
      Rozerem vs. placebo on gastroesophageal reflux disease(GERD) symptomatology as the primary
      outcome, and sleep quality and quality of life as secondary outcomes.
    
  